05.28.24 -- A Promising Approach To Develop An Inhalable, Temperature-Stable COVID-19 Vaccine

The pharma industry is identifying ways to make processes more sustainable. Learn how nanoparticle engineering technology can both empower sustainability goals and lead to better patient outcomes.

Gain insights to help you better approach regulatory policies along with helpful strategies to facilitate efficient regulatory review and drug approval.

Understand the importance of fate and purge studies, which measure the ability of the process to remove impurities and provide evidence of their removal.

Examine the challenges faced by a large CDMO as well as the solutions that were provided to achieve significant time savings, cost savings, and the removal of a major downstream process limitation.

Combination therapies delivered directly to the lung by dry powder inhalants reduce patient burden and improve care. Explore case studies illustrating the potential for improving care for critically ill patients.

Are you up to the task of bringing a biologic drug to market? Do you have a strategy and plan for moving forward? Consider guidelines from a biopharma process development and manufacturing perspective.

Review an integrated service package designed to simplify and accelerate the development pathway, even for APIs with challenging properties such as low aqueous solubility and poor bioavailability.